Creative Medical Technology Holdings, Inc. (CELZ) has a negative trailing P/E of -0.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -116.36%, forward earnings yield 161.29%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 51/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -69.9 | -0.21 | -339.37 | 0.00 | - |
| 2017 | -0.6 | 0.00 | -0.69 | 322.73 | - |
| 2018 | -0.7 | 0.02 | -2.24 | 71.80 | - |
| 2019 | -0.1 | 0.00 | -0.06 | 2.81 | - |
| 2020 | -0.2 | 0.00 | -0.20 | 48.96 | - |
| 2021 | 0.3 | 0.00 | 0.56 | 65.61 | - |
| 2022 | -0.4 | 0.00 | 0.26 | 47.01 | - |
| 2023 | -1.2 | 0.02 | 0.63 | 721.02 | - |
| 2024 | -0.6 | 0.47 | 0.54 | 310.89 | - |
| 2025 | -0.8 | 0.02 | 0.62 | 778.38 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-5,471.94 | $0.00 | $-766.07K | - |
| 2017 | $-17,379.80 | $4.8K | $-2.66M | -55398.1% |
| 2018 | $-11,351.30 | $124.4K | $-13.66M | -10977.2% |
| 2019 | $-5,017.67 | $165.5K | $-10.38M | -6271.4% |
| 2020 | $-648.10 | $164.5K | $-37.55M | -22829.7% |
| 2021 | $45.97 | $87.75K | $14.93M | 17017.3% |
| 2022 | $-9.19 | $88.6K | $-10.04M | -11336% |
| 2023 | $-3.76 | $9K | $-5.29M | -58739.7% |
| 2024 | $-3.71 | $11K | $-5.49M | -49940.7% |
| 2025 | $-2.52 | $6K | $-6M | -99916.8% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.40 | $-1.40 – $-1.40 | $23.41M | $23.41M – $23.41M | 1 |
| 2027 | $-1.35 | $-1.35 – $-1.35 | $33.83M | $33.83M – $33.83M | 1 |
| 2028 | $3.67 | $3.67 – $3.67 | $60.08M | $60.08M – $60.08M | 1 |
| 2029 | $4.78 | $4.78 – $4.78 | $82.97M | $82.97M – $82.97M | 1 |
| 2030 | $5.77 | $5.77 – $5.77 | $100.83M | $100.83M – $100.83M | 1 |
